Ramakrishna Pharma Private Limited, a active private limited company, was established on 12 March 2008 in Mysore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24296KA2008PTC045574. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹0.60 M.
It upholds a compliant status. Employing 24 professional, Its leadership includes Narendra Babu Ambika (Director), Mythili Venugopal Mudaliar Muniswamy (Director), Narendrababu Natarajan (Managing Director). Past directors included Raghavan Subramanyan, Narendra Babu Ambika, Sudhakar Perumalswamy Mysore. It holds ₹1.50 Cr open charges and ₹1.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.1498/3, Ch-17, Rama Iyer Road, Krishnamurthypuram, Mysore, Karnataka, 570004.
U24296KA2008PTC045574
045574
12 March 2008
₹3.00 M
₹0.60 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Ramakrishna Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Narendra Babu Ambika | Director | 25 Nov 2023 | Current |
| Mythili Venugopal Mudaliar Muniswamy | Director | 05 May 2008 | Current |
| Narendrababu Natarajan | Managing Director | 12 Mar 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 May 2008 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 03 Aug 2009 | Past |
| Pramod Abcsdd | Director | 05 May 2008 | Past |
| Pramod Abcsdd | Additional Director | 03 Aug 2009 | Past |
| Pramod Abcsdd | Director | 10 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ramakrishna Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.2% increase. The company also saw a substantial improvement in profitability, with a 107.41% increase in profit. The company's net worth Soared by an impressive increase of 27.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Ramakrishna Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹15,000,000.00
₹15,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 May 2020 | Others | ₹1.50 Cr | Open |
| 06 Oct 2008 | State Bank Of India | ₹1.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Ramakrishna Pharma has a workforce of 24 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ramakrishna Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ramakrishna Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ramakrishna Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Ramakrishna Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was completed.
Narendra Babu Ambika was appointed as a Director was appointed as a Director on 25 Nov 2023 & has been associated with this company since 2 years 23 days . was recorded as a recent event.
The activity A charge with Others amounted to Rs. 15.00 M with Charge ID 100346379 was registered on 14 May 2020. was completed.
The activity A charge registered on 06 Oct 2008 via Charge ID 10125370 with State Bank Of India was fully satisfied on 18 Mar 2020. was completed.
Progress on A charge with State Bank Of India of Rs. 15.00 M registered on 06 Oct 2008 with Charge ID 10125370 was modified on 24 Jun 2019. was documented.
The CIN of Ramakrishna Pharma Private Limited is U24296KA2008PTC045574.
Ramakrishna Pharma Private Limited is headquartered at No.1498/3, Ch-17, Rama Iyer Road, Krishnamurthypuram, Mysore, Karnataka, 570004.
Ramakrishna Pharma Private Limited was incorporated on 12 March 2008.
The current directors of Ramakrishna Pharma Private Limited are
The primary industry of Ramakrishna Pharma Private Limited is Trade.
Ramakrishna Pharma Private Limited is unlisted.
The authorized capital of Ramakrishna Pharma Private Limited is ₹3.00 M, and the paid-up capital is ₹0.60 M.
The compliance status of Ramakrishna Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX